Vtama® (tapinarof) 1% cream has been approved to treat plaque psoriasis in adults.

• Vtama is the first novel topical treatment for plaque psoriasis to receive FDA approval in 25 It is also the first steroid-free topical medication in its class.
• Recommended dosing is a thin layer of cream applied to the affected area once daily.
• Manufacturer Dermavant Sciences has launched the product at a wholesale acquisition cost (WAC) of $1,325 per 60g tube.